Prescription drug · ANDA
Methylprednisolone Sodium Succinate NDC 55150-264
Methylprednisolone sodium succinate 500 mg/1 · Injection, Powder, Lyophilized, For solution · Intramuscular, Intravenous · Eugia US LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 55150-264-20 | 55150026420 | 1 VIAL, MULTI-DOSE in 1 CARTON (55150-264-20) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, MULTI-DOSEMarketed from Dec 15, 2015 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Methylprednisolone Sodium Succinate
- Generic name (nonproprietary)
- methylprednisolone sodium succinate
- Active ingredients
- Methylprednisolone sodium succinate — 500 mg/1
- Dosage form
- Injection, Powder, Lyophilized, For solution
- Route
- Intramuscular, Intravenous
- Labeler
- Eugia US LLC
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 207667
- Marketing start
- Listing expires
- Other FDA classes
- Corticosteroid Hormone Receptor Agonists (Mechanism)
- Identifiers
- Product ID 55150-264_6e09ea9a-c9a2-409c-96a8-582180d6160eSPL ID 6e09ea9a-c9a2-409c-96a8-582180d6160eSPL set ID 2035f00e-2299-473a-b004-cb93f541cfa9RxCUI 311659, 314099, 1357886, 1743704UNII LEC9GKY20KUPC 0355150265503, 0355150264209
- Pharmacologic class
- Corticosteroid
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N455150026420followed by a unit qualifier and the quantityPackage 55150-0264-20. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE When oral therapy is not feasible, and the strength, dosage form, and route of administration of the drug reasonably lend the preparation to the treatment of the condition, the intravenous or intramuscular use of methylprednisolone sodium succinate for injection is indicated as follows: Allergic states: Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, serum sickness, transfusion reactions. Dermatologic diseases: Bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, severe erythema multiform…
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 207667
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Methylprednisolone Sodium Succinate | Methylprednisolone sodium succinate 125 mg/1 | Injection, Powder, Lyophilized, For solutionIntramuscular, Intravenous | Eugia US LLC | 55150-263 |
| Methylprednisolone Sodium Succinate | Methylprednisolone sodium succinate 40 mg/1 | Injection, Powder, Lyophilized, For solutionIntramuscular, Intravenous | Eugia US LLC | 55150-262 |
| Methylprednisolone Sodium Succinate | Methylprednisolone sodium succinate 2 g/1 | Injection, Powder, Lyophilized, For solutionIntramuscular, Intravenous | Eugia US LLC | 55150-265 |